HMGA2 and colorectal carcinoma: Along with let-7 expression, HMGA2 has been determined to be a predictive biomarker of poor clinical outcomes in many epithelial and hematopoietic malignancies including acute myeloid leukemia [182], ovarian and colorectal carcinoma [162,169], and oral squamous cell carcinoma [183].